Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 14, 2007 - Issue 2
34
Views
17
CrossRef citations to date
0
Altmetric
Regular Articles

Effects of β-Endorphin on Endothelial/Monocytic Endothelin-1 and Nitric Oxide Release Mediated by μ1-Opioid Receptors: A Potential Link between Stress and Endothelial Dysfunction?

, , , &
Pages 65-71 | Received 20 Jun 2006, Accepted 25 Feb 2007, Published online: 13 Jul 2009
 

Abstract

Observations have been made linking the presence of psychosocial factors associated with elevated β-endorphin concentrations with atherosclerosis. In this study, the authors assume an important role of the stress hormone β-endorphin in several mechanisms that contribute to a dysbalance of human endothelial and monocytic endothelin (ET)-1 and nitric oxide (NO) release, mediated by μ1-opioid receptors. ET-1 and NO release were quantified via enzyme-linked immunosorbent assay (ELISA) or fluorometrically. μ1-Opioid receptors were identified by polymerase chain reaction (PCR) after stimulation with β-endorphin. β-Endorphin significantly increased endothelial and monocytic ET-1 release. The effect was mediated by μ1-opioid receptors and abolished by naloxonazine, a selective μ1-opioid receptor antagonist. In contrast, NO release was decreased under the influence of β-endorphin. μ1-Opioid receptors on human monocytes and endothelial cells mediated a β-endorphin–induced stimulation of ET-1 release, whereas NO release was decreased. Thus, the authors hypothesize a role of β-Endorphin in the pathogenesis of stress-induced endothelial dysfunction through peripherally circulating β-endorphin, which may offset the balance of vasoactive mediators, leading to an unopposed vasoconstriction. The data may also provide a new concept of μ1-opioid receptor antagonists, preventing β-endorphin–induced disorders of vascular biology.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.